Journal
Blood Reviews
Publication Date
5-1-2024
Volume
65
First Page
101184
Document Type
Open Access Publication
DOI
10.1016/j.blre.2024.101184
Rights and Permissions
Uy GL, DeAngelo DJ, Lozier JN, Fisher DM, Jonas BA, Magnani JL, Becker PS, Lazarus HM, Winkler IG. Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy? Blood Rev. 2024 May;65:101184. doi: 10.1016/j.blre.2024.101184 /© 2024 GlycoMimetics, Inc. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Uy, Geoffrey L; DeAngelo, Daniel J; Lozier, Jay N; Fisher, Dennis M; Jonas, Brian A; Magnani, John L; Becker, Pamela S; Lazarus, Hillard M; and Winkler, Ingrid G, "Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?." Blood Reviews. 65, 101184 (2024).
https://digitalcommons.wustl.edu/oa_4/5018
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
